Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université Laval

$28,000.00

Diversification of rhamnolipids/glycolipids in heterologous lipogenic yeast hosts using synthetic biology

EF 2022-23

Résumé
Glycolipids (GLs) are produced by diverse organisms, particularly by yeasts and bacteria. The most prominent GLs are rhamnolipids (RLs) that exist in a diversity of RL congeners and homologs. Although their exact physiological functions are unknown, RLs are thought to be produced as defense or survival mechanisms in response to unfavorable environmental conditions. RLs are considered virulence factors of pathogenic microorganisms like Pseudomonas aeruginosa as they help in the colonization of biotic surfaces of humans and plants. Nonetheless, RLs have interesting antimicrobial, antiparasitic, anticancer, immunomodulatory, anti-adherent as well as surface activities allowing them to find several medical, agricultural, environmental, and industrial applications. It is noteworthy that these activities are vary with variations in RL structures creating thus a diversity of biological and physical activities. This richness in biological and physical activities incited the search for new RLs with potentially novel or more interesting activities. Nonetheless, the discovery of new RLs has slowed down drastically in the last decades because it relied on classical screening of new RL producers isolated from environmental samples. This resulted in the redundant identifications of the same RL-producers that are producing the same RLs molecules. Another problem facing RLs commercialization is their costly production arising mainly from the pathogenic nature of their best producers, like P. aeruginosa which is an opportunistic human pathogen. Such pathogenic nature of RL-producers requires costly biocontainment measures which adds to the net cost of RLs. Under the goal to overproduce structurally diverse RLs in non-pathogenic microbial hosts, we set our short-term objective for program to develop proof-of-concept strategies for the genome-mining based heterologous production of diverse RLs in the non-pathogenic lipogenic yeast host, Yarrowia lipolytica. This involves the design of synthetic metabolic circuits biosynthesizing RLs, building and integrating genetic constructs into Yarrowia lipolytica, and finally testing and identification of produced RLs. This design-build-test synthetic biology cycles will be iteratively repeated until the desired RL congener or homolog is produced. In subsequent discovery grants, we will use these strategies to overproduce interesting RL congener or homologs at satisfactory yields and at low cost. This research program will ultimately result in the low-cost production of a diversity of designer RL molecules associated with interesting biological and physical activities that are useful for many therapeutic, environmental, and industrial applications. It will also result in the production of several original research articles, filing of patents and training of highly qualified professionals at undergraduate and graduate levels who will competently contribute to the rising chemical synthetic biology domain in Canada.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2022-05307
Name nom
Saleh, Ahmad
Department département
Biochimie, de microbiologie et de bio-informatique - Biochimie, de microbiologie et de bio-informatique
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Installment
inst:1
Partie
1
Nb partie
5
Application title
Diversification of rhamnolipids/glycolipids in heterologous lipogenic yeast hosts using synthetic biology
Application summary
Glycolipids (GLs) are produced by diverse organisms, particularly by yeasts and bacteria. The most prominent GLs are rhamnolipids (RLs) that exist in a diversity of RL congeners and homologs. Although their exact physiological functions are unknown, RLs are thought to be produced as defense or survival mechanisms in response to unfavorable environmental conditions. RLs are considered virulence factors of pathogenic microorganisms like Pseudomonas aeruginosa as they help in the colonization of biotic surfaces of humans and plants. Nonetheless, RLs have interesting antimicrobial, antiparasitic, anticancer, immunomodulatory, anti-adherent as well as surface activities allowing them to find several medical, agricultural, environmental, and industrial applications. It is noteworthy that these activities are vary with variations in RL structures creating thus a diversity of biological and physical activities. This richness in biological and physical activities incited the search for new RLs with potentially novel or more interesting activities. Nonetheless, the discovery of new RLs has slowed down drastically in the last decades because it relied on classical screening of new RL producers isolated from environmental samples. This resulted in the redundant identifications of the same RL-producers that are producing the same RLs molecules. Another problem facing RLs commercialization is their costly production arising mainly from the pathogenic nature of their best producers, like P. aeruginosa which is an opportunistic human pathogen. Such pathogenic nature of RL-producers requires costly biocontainment measures which adds to the net cost of RLs. Under the goal to overproduce structurally diverse RLs in non-pathogenic microbial hosts, we set our short-term objective for program to develop proof-of-concept strategies for the genome-mining based heterologous production of diverse RLs in the non-pathogenic lipogenic yeast host, Yarrowia lipolytica. This involves the design of synthetic metabolic circuits biosynthesizing RLs, building and integrating genetic constructs into Yarrowia lipolytica, and finally testing and identification of produced RLs. This design-build-test synthetic biology cycles will be iteratively repeated until the desired RL congener or homolog is produced. In subsequent discovery grants, we will use these strategies to overproduce interesting RL congener or homologs at satisfactory yields and at low cost. This research program will ultimately result in the low-cost production of a diversity of designer RL molecules associated with interesting biological and physical activities that are useful for many therapeutic, environmental, and industrial applications. It will also result in the production of several original research articles, filing of patents and training of highly qualified professionals at undergraduate and graduate levels who will competently contribute to the rising chemical synthetic biology domain in Canada.